Background: Clostridium difficile infection (CDI) is still a major challenge to healthcare facilities. The detection of multiple C. difficile strains has been reported in some patient samples during initial and recurrent CDI episodes. However, the behaviour of individual strains and their contribution to symptomatic disease is unclear. Methods: An in vitro human gut model was used to investigate the germination and proliferation of two distinct C. difficile strains during initial and recurrent simulated CDI, as well as their response to vancomycin treatment. The gut model was inoculated with a pooled human faecal emulsion and indigenous gut microbiota, C. difficile populations (vegetative and spore forms), cytotoxin levels and antimicrobial...
Background For over 4 decades, Clostridium difficile has been a significant enteric pathogen of h...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
One of the main clinical challenges of Clostridium difficile infections (CDI) is the high rate of re...
Objectives: Clostridium difficile infection (CDI) is still a major challenge to healthcare facilitie...
Objectives: Vancomycin and metronidazole remain the only primary options for the treatment of Clostr...
Clostridium difficile is a unique pathogen that often predominates in the bowel microflora as a resu...
Given that Clostridium difficile is not part of the normal human microbiota, if multiple strains are...
BACKGROUND:Clostridium difficile infection (CDI) is a significant nosocomial infection worldwide, th...
Clostridium difficile infection (CDI) following antibiotic therapy is a major public health threat. ...
The beneficial effect of colonization of the gastrointestinal tract by non-toxigenic Clostridioides ...
lostridium difficile infection (CDI), most often resulting from an antibiotic-induced disturbance of...
Abstract Objectives: Effects of two vancomycin extended-dosing regimens on microbiota populations wi...
Objective A frequent complication of Clostridium difficile infection (CDI) is recurrent disease. The...
Background: Recurrent Clostridium difficile infection (rCDI) places a huge economic and practical bu...
C. difficile infection (CDI) is the cause of an intestinal disease mediated by two potent cytotoxins...
Background For over 4 decades, Clostridium difficile has been a significant enteric pathogen of h...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
One of the main clinical challenges of Clostridium difficile infections (CDI) is the high rate of re...
Objectives: Clostridium difficile infection (CDI) is still a major challenge to healthcare facilitie...
Objectives: Vancomycin and metronidazole remain the only primary options for the treatment of Clostr...
Clostridium difficile is a unique pathogen that often predominates in the bowel microflora as a resu...
Given that Clostridium difficile is not part of the normal human microbiota, if multiple strains are...
BACKGROUND:Clostridium difficile infection (CDI) is a significant nosocomial infection worldwide, th...
Clostridium difficile infection (CDI) following antibiotic therapy is a major public health threat. ...
The beneficial effect of colonization of the gastrointestinal tract by non-toxigenic Clostridioides ...
lostridium difficile infection (CDI), most often resulting from an antibiotic-induced disturbance of...
Abstract Objectives: Effects of two vancomycin extended-dosing regimens on microbiota populations wi...
Objective A frequent complication of Clostridium difficile infection (CDI) is recurrent disease. The...
Background: Recurrent Clostridium difficile infection (rCDI) places a huge economic and practical bu...
C. difficile infection (CDI) is the cause of an intestinal disease mediated by two potent cytotoxins...
Background For over 4 decades, Clostridium difficile has been a significant enteric pathogen of h...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
One of the main clinical challenges of Clostridium difficile infections (CDI) is the high rate of re...